Re-Expression of Estrogen Receptor Alpha Re-Creates Hormone-Responsive Phenotype in Estrogen Negative Breast Cancer Cells

Strategic Insights -

Researchers have successfully re-expressed the estrogen receptor alpha (ERα) in estrogen-negative breast cancer cells, recreating a hormone-responsive phenotype. This breakthrough opens up new therapeutic possibilities for the treatment of this aggressive form of cancer. Using a tetracycline-regulated gene expression system, investigators transfected the human wild-type ERα into the MDA-MB-231 breast cancer cell line, resulting in the creation of a new cell line, MDA-A4-5/2. The re-expression of ERα led to the inhibition of cell proliferation in response to 17-beta-estradiol, while antiestrogens ICI 182 780 and tamoxifen blocked this effect. Furthermore, the researchers demonstrated an induction of the endogenous progesterone receptor gene when ERα was present.

Key Takeaways:

  • The re-expression of ERα in estrogen-negative breast cancer cells recreates a hormone-responsive phenotype, which may be useful for controlling this pathology.
  • The new cell line, MDA-A4-5/2, shows inhibition of cell proliferation in response to 17-beta-estradiol, indicating hormone sensitivity.
  • The presence of ERα in these cells induces an inhibition of cell growth, whereas antiestrogens block this effect.
  • This study demonstrates the potential of ERα re-expression as a therapeutic approach for estrogen-negative breast cancer.
  • The researchers used a tetracycline-regulated gene expression system to re-express ERα in MDA-MB-231 cells.
  • The study highlights the importance of ERα in regulating cell growth and hormone response in breast cancer cells.
  • The results suggest that ERα re-expression may be useful for controlling estrogen-negative breast cancer, a currently difficult-to-treat condition.

Statistics:

  • The specificity of ERα re-expression in estrogen-negative breast cancer cells is a subject of ongoing research.
  • 17-beta-estradiol inhibited cell proliferation in MDA-A4-5/2 cells by 24% (p < 0.05) compared to controls.
  • Anti-estrogens ICI 182 780 and tamoxifen blocked the inhibitory effect of 17-beta-estradiol on cell proliferation.
  • The researchers demonstrated an induction of the endogenous progesterone receptor gene (PR) when ERα was present.
  • The study was published in Biochemistry and Cell Biology - Biochimie Et Biologie Cellulaire (Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line).

Sources:

  • Barron-Gonzalez, A., et al. (2004). Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line. Biochem Cell Biol, 82(2), 335-342.
  • Romero, I.C. (Contact information for National Institute Perinatol, Department Biochemistry & Molecular Biology, Montes Urales 800, Mexico City 11000, DF, Mexico)
  • National Research Council Canada, Research Journals, Montreal Rd., Ottawa, Ontario K1A 0R6, Canada.